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The hypothalamic neuropeptide oxytocin (OT), which
controls childbirth and lactation, receives increasing
attention for its effects on social behaviors, but how it
reaches central brain regions is still unclear. Here we
gained by recombinant viruses selective genetic
access to hypothalamic OT neurons to study their
connectivity and control their activity by optogenetic
means. We found axons of hypothalamic OT neurons
in the majority of forebrain regions, including the
central amygdala (CeA), a structure critically involved
in OT-mediated fear suppression. In vitro, exposure
to blue light of channelrhodopsin-2-expressing OT
axons activated a local GABAergic circuit that in-
hibited neurons in the output region of the CeA.
Remarkably, in vivo, local blue-light-induced endog-
enous OT release robustly decreased freezing
responses in fear-conditioned rats. Our results thus
show widespread central projections of hypotha-
lamic OT neurons and demonstrate that OT release
from local axonal endings can specifically control
region-associated behaviors.
INTRODUCTION
Oxytocin (OT) is an evolutionarily ancient neuropeptide found in
species ranging from invertebrates to mammals (Donaldson and
Young, 2008). In mammals, the major sources of OT are the
hypothalamic paraventricular (PVN), supraoptic (SON), and
accessory magnocellular nuclei (AN) (Sofroniew, 1983; Swanson
and Sawchenko, 1983). Axons of the vast majority of OT neurons
and vasopressin (VP) neurons terminate in the posterior lobe of
the pituitary, forming the classic hypothalamic-neurohypophy-
seal system (Brownstein et al., 1980). From the posterior pitui-tary, OT reaches the general blood circulation and acts on target
organs, exerting uterine contraction and milk ejection from the
mammary glands.
Besides thesewell-known neuroendocrine effects, OT attracts
increasing interest for its effects in the forebrain, affecting fear,
trust, and other social behaviors (Lee et al., 2009). OT exerts
powerful anxiolytic effects (Neumann, 2008) in the central
nucleus of amygdala (CeA), the core brain structure underlying
fear responses (Hitchcock and Davis, 1991; Kapp et al., 1979;
Wilensky et al., 2006). In the lateral CeA (CeL), local application
of OT activates a subpopulation of GABAergic interneurons
that inhibits neurons in the medial CeA (CeM), the main output
of the CeA to the brainstem (Huber et al., 2005), thereby attenu-
ating behavioral fear responses (Viviani et al., 2011).
Although these behavioral effects of OT are well documented,
the pathway through which OT reaches the amygdala and other
forebrain regions and its precise cellular origins still remain
unknown. Systemic OT cannot pass the blood-brain barrier
(McEwen, 2004), and hence, there must be central OT release.
The prevailing hypothesis over the last 20 years has been that
central OT function is mediated by dendritic OT release in the
hypothalamus, followed by passive diffusion to various brain
structures (Landgraf and Neumann, 2004; Ludwig and Leng,
2006; Veenema and Neumann, 2008). However, OT receptors
(OT-R; Gimpl and Fahrenholz, 2001) occur throughout the brain
at various distances from the hypothalamus, and hence, passive
diffusion would put severe limitations on the time course and
specificity of OT signaling. Such limitations could be overcome
by long-range axonal projections of hypothalamic OT neurons
(Ross and Young, 2009).
To resolve this important outstanding issue in the field, we
sought evidence for axonal OT-containing processes of hypo-
thalamic origin that demonstrate functional OT release. To visu-
alize OT axons, we selectively expressed fluorescent marker
proteins from an OT gene promoter by infecting hypothalamic
neurons with a recombinant adeno-associated virus (rAAV).
Expression and activation of rAAV-directed channelrhodopsin-
2 (ChR2; Nagel et al., 2003) in OT neurons revealed that blue lightNeuron 73, 553–566, February 9, 2012 ª2012 Elsevier Inc. 553
Figure 1. Cell-Type Specificity of Virally
Infected OT Neurons
(A) An rAAV-expressing Venus under the control of
a 2.6 kb mouse OT promoter was injected into
PVN and SON of adult female rats.
(B) Viral infection resulted in Venus expression in
OT, but not VP, neurons.
(C) Increased intrinsic Venus fluorescence inten-
sity (FI) and sizes of cell bodies in the SON on the
day before delivery (blue), day of delivery (orange)
and day after delivery (green) compared to virgin
rats (gray), as presented in graphs below. *p <
0.01. Scale bars represent 50 mm in (B) and (C) and
10 mm in insets in (B). 3v, third ventricle; opt, optic
tract.
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Evoked Axonal Oxytocin Releasetriggered, in vitro, an OT-receptor-mediated increase in neuronal
activity in the CeL, enhanced the frequency of inhibitory postsyn-
aptic currents (IPSCs) in the CeM, and decreased, in vivo,
context-evoked freezing responses in fear-conditioned rats.
Our findings provide direct evidence for local, endogenous OT
signaling in the suppression of CeA-mediated fear (Roozendaal
et al., 1992a, 1992b; Viviani et al., 2011).
RESULTS
Specificity of Virus-Directed Gene Expression in
Neurons of the Rat Hypothalamus
We constructed an rAAV-expressing Venus from a 2.6 kb region
upstream of OT exon 1 (Figure 1A) and conserved in mammalian
species (see Experimental Procedures). The injection of this
rAAV into the PVNor SONof rats (Figure 1A) resulted in the selec-
tive expression of Venus in OT, but not VP, neurons (Figure 1B).
Quantitative analysis in the SON, PVN, and AN of virgin and
lactating rats showed more than 97% colocalization of OT and
Venus expression and only 1.70% ± 0.36% of Venus-positive
neurons expressing VP, revealing a very efficient and highly
specific virus expression (Table 1).
The virally introduced OT promoter appears to be regulated
during late pregnancy (Zingg and Lefebvre, 1988) and lactation
(Burbach et al., 2001), like its chromosomal counterpart. We
indeed found a 3-fold increase in fluorescent intensity, as well
as larger sized green fluorescent OT cells around delivery
compared to virgin rats (Figure 1C), in accordance with earlier554 Neuron 73, 553–566, February 9, 2012 ª2012 Elsevier Inc.studies (Theodosis, 2002). Despite these
differences in size and Venus expression,
we found no significant changes in the
absolute numbers of identified OT
neurons (Table 1).
Efferent Projections from
Hypothalamic OT Neurons to
Forebrain Structures
In view of these important differences in
OT expression, we used lactating rats to
reveal the fine, thin projections of OT
axonal arbors in the forebrain (see Fig-ure S1 available online). OT neurons of the PVN and SON pro-
jected to a wide range of OT-R-expressing forebrain structures
(Figures 2 and S2; Gimpl and Fahrenholz, 2001), though PVN
neurons provided many more prominent projections to more
numerous structures (29 of 34 regions analyzed; Figure 2) than
SON neurons (five regions; see Figure S2 for quantification).
Previous studies reported high OT-R expression and OT-R-
mediated effects in the CeA, a structure critically involved in
the expression of conditioned fear (Huber et al., 2005; Bosch
et al., 2005). We found Venus-positive processes from the PVN
to engulf and enter the CeA but only marginally observed single
Venus-positive processes from the SON, mostly at the ventro-
lateral CeA (Figures 3 and S2). In animals targeted in all OT
nuclei, including AN, we observed significantly more Venus-
positive fibers in the CeA, preferentially located in the CeL
(Figures 3A and S3). These contained OT-positive puncta (Fig-
ure 3B), confirming their exclusive origin from OT neurons (see
Figure S3 for quantification).
Cytochemical Markers in CeA Projections from
Hypothalamic OT Neurons
At the light microscopic level, the small-diameter, branching,
and en passant varicosities of Venus-positive processes sug-
gested that the above-observed fibers were axons. To corrobo-
rate their axonal nature, we expressed in OT neurons the axonal
marker Tau tagged by enhanced green fluorescent protein
(EGFP). We observed an EGFP signal in all fibers within the
CeA and in axonal terminals in the posterior pituitary (Figure 3C).
Table 1. Quantification of OT-Promoter Specificity in OT-ergic Nuclei in the Hypothalamus of Virgin and Lactating Rats. Results are
Presented as Percentage ± SEM.
Animals Comparison SON PVN rSON CN DLN
Virgin Rats OT versus Venus 99.57% ± 0.66% 99.8% ± 0.49% 99.07% ± 2.27% 98.48% ± 3.71% 98.47% ± 2.59%
n = 1,091 n = 936 n = 115 n = 69 n = 210
Venus versus OT 98.01% ± 3.09% 97.34% ± 2.03% 98.13% ± 2.97% 97.57% ± 3.82% 97.66% ± 2.15%
n = 1,091 n = 936 n = 115 n = 69 n = 210
Lactating Rats OT versus Venus 100% 99.57% ± 0.85% 100% 100% 99.56% ± 1.07%
n = 987 n = 969 n = 116 n = 74 n = 207
Venus versus OT 99.06% ± 1.48% 99.06% ± 2.3% 100% 100% 99.55% ± 1.10%
n = 987 n = 969 n = 116 n = 74 n = 207
n, absolute number of identified neurons per structure and condition; CN, circular nucleus; DLN, dorsolateral nucleus; rSON, retrochiasmatic part of
the SON.
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vealed synaptic terminals in both structures (Figure 3D). Costain-
ing of synaptophysin-EGFP puncta with antibodies against OTFigure 2. Distributions of Venus-Labeled OT Fibers from the PVN in
Extrahypothalamic Forebrain Regions of Lactating Rats
(A and B) OT/GFP fiber pattern in subcortical (A) and cortical (B) areas. The
infected PVN in one hemisphere is colored in green. The density of fibers is
depicted in the following colors: yellow, orange, red, and violet. The detailed
information on forebrain projections from ipsi- and contralateral PVN and SON,
as well as examples of stained GFP fibers, are presented in Figure S2. For
abbreviations of structures, see Figure S2.and vesicular glutamate transporter 2 (VGluT2), the mRNA of
which was detected in OT neurons (Kawasaki et al., 2005),
demonstrated overlap of EGFP, VGluT2, and OT signals (Fig-
ure 3E), confirming previous reports on magnocellular neurons
enriched by microvesicles that associate with synaptophysin
(Navone et al., 1989) and contain glutamate (Meeker et al.,
1991). Higher-resolution electron microscopic analysis revealed
the presence of synaptic contacts between immunoreactive
axon terminals and local dendrites in the CeL (Figure 3F), most
likely dendrites of GABAergic interneurons, of which the CeL is
predominantly composed (Davis, 2000; Huber et al., 2005). In
the three cases analyzed, we encountered synaptic appositions
bearing the features of asymmetric (Gray’s type 2) synapses,
proposed to be of excitatory nature (Figure 3F). Importantly,
we were unable to find synaptic contacts within the CeM (M.E.,
unpublished data), where fibers are traversing the region without
branching and forming varicosities, as was the case in the CeL
(Figure S3A). Our collective findings strongly suggest a presence
in the CeL of axonal terminals that originate fromOT neurons and
form glutamatergic synapses.
Blue-Light Activation of ChR2-Expressing Axons In Vitro
Induces Local OT Release
Based on the anatomical evidence for OT-containing axonal
fibers of hypothalamic origin in the CeA, we selectively ex-
pressed the blue-light (BL)-sensitive ChR2 protein (Nagel et al.,
2003) fused to mCherry (Figure 4A) in all hypothalamic OT
neurons via an rAAV. Whole-cell voltage-patch-clamp record-
ings in vitro in coronal slices ofmCherry fluorescent cells (Figures
4A and 4B, top) revealed functional ChR2 expression in PVN,
SON, and AN neurons, as evident from the presence of BL
induced currents with a characteristic rapidly inactivating peak
followed by a stable tail (Boyden et al., 2005; Figures 4C and
S4). Because high frequencies of action potentials are thought
to be necessary to trigger release of neuropeptides, in contrast
to release of classical neurotransmitters (Ho¨kfelt, 1991), we
quantified the effect of different BL stimulations on AP frequen-
cies of PVN and SON neurons. Current-clamp recordings from
these neurons showed that AP frequencies up to 20 Hz could
be reliably induced by stimulation frequencies with short BL
pulses of 10 ms applied at 30 Hz, as well as by continuous BL
exposure (Figures 4C and S4A).Neuron 73, 553–566, February 9, 2012 ª2012 Elsevier Inc. 555
Figure 3. Venus-Positive Fibers from OT Neurons within the CeA
Exhibit Axonal Features and Form Synapses
(A) Venus-positive fibers in the CeA originate from the PVN, SON, and AN and
are infected with rAAV-expressing Venus from the OT promoter. The confocal
images of the right CeAs were taken from coronal sections of the nucleus
at Bregma, 2.7 mm. The external borders and the approximate borders
Neuron
Evoked Axonal Oxytocin Release
556 Neuron 73, 553–566, February 9, 2012 ª2012 Elsevier Inc.Having shown functional ChR2 expression in the OT cell
bodies, we tested whether BL could also release endogenous
OT from axonal projections in horizontal slices of the CeA (Fig-
ure 4B, bottom). Exposure of the CeL to BL (20 s) evoked clear,
reversible increases in AP frequencies in one-third (11/33) of
CeL neurons in cell-attached recordings (from 0.24 ± 0.02 to
0.85 ± 0.24 Hz; Student’s t test, p < 0.01; Figures 4D1 and
4D2). Preincubation with the OT-receptor antagonist (OTA),
though not affecting basic AP frequencies, significantly and
reversibly blocked these increases (>70% remaining response
0.46 ± 0.09 Hz, n = 5; one-way analysis of variance [ANOVA],
p < 0.05; Figures 4D1 and 4D2). The GABA(A) blocker picrotoxin
(PTX) caused, on average, a significant increase in baseline AP
frequencies (from 0.27 ± 0.09 to 0.61 ± 0.26 Hz, n = 5; one-
way ANOVA, p < 0.05), possibly as a result of inhibition of local
inhibitory circuits in the CeL (Ciocchi et al., 2010; Haubensak
et al., 2010). In summary, endogenous release of OT from hypo-
thalamic fibers leads to an efficient, OT-R-mediated activation of
CeL neurons.
Because CeL neurons project to and release GABA in the CeM
(Huber et al., 2005), we also tested for rapid transient increases in
IPSC frequencies in the CeM. CeL exposure to BL (20 s) evoked
abrupt increases in IPSC frequencies in 36 out of 107 testedCeM
neurons (Figure 4B, bottom trace and Figure 4E1), on average
from 0.5 ± 0.1 Hz to 3.7 ± 0.8 Hz (Figure 4E2, first panel;
Student’s t test, p < 0.01), without affecting average IPSC ampli-
tudes (Figure S4B). These increases depended on the precise
area exposed to BL. Thus, BL applied outside the CeL, e.g.,
focused on the CeM (Figure 4E2, fifth panel, n = 6), never modi-
fied IPSC frequencies in CeM neurons that responded with
increases in IPSCs after BL exposure of the CeL. Similar to the
AP increases in the CeL (Figure 4D2), these increases in IPSC
frequencies in CeM were significantly and reversibly blocked
by OTA (>70%, 1.3 ± 0.2 Hz, n = 9; one-way ANOVA, p < 0.05;
Figure 4E2, third panel). Subsequent PTX application blocked
spontaneous IPSCs as well as any further BL effects (n = 5, Fig-
ure 4E2, fourth panel), confirming the GABAergic nature of the
observed responses.
Although OTA significantly inhibited BL-induced increases of
AP frequencies in the CeL and IPSC frequencies in the CeM, in
both cases small but significant responses remained. In both
CeA subdivisions, these responses could be entirely abolished
by adding the AMPA-receptor antagonist NBQX to theOTA incu-
bations (Figure 4D2, left panel, 0.25 ± 0.01 Hz for APs, n = 5; and
Figure 4E2, third panel, 0.6 ± 0.1Hz for IPSCs, n = 4). Thisbetween CeL (comprising two parts, the central central and central lateral) and
the CeM are outlined.
(B) OT-immunoreactive puncta along Venus-positive fibers.
(C and D) Tau-EGFP (C) and Synaptophysin-EGFP (D) signals detected in OT
fibers within the CeA and posterior pituitary. In (A)–(D), the brain sections were
costained with antibody against the neuronal marker NeuN and were visual-
ized in red by CY-3 conjugated antibodies.
(E) Synaptophysin-EGFP puncta overlap with OT and VGlut2.
(F) Asymmetric synapses in the CeL, formed by GFP-positive axonal terminals
(at) of OT neurons on dendrites (d) of amygdala neurons. Scale bars represent
100 mm in (A), 5 mm in (B) and (E), 10 mm in left panels in (C) and (D), 100 mm in
right panels in (C) and (D), and 250 nm and 500 nm for left and right electro-
nograms, respectively, in (F).
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Figure 4. ChR2-Evoked Oxytocin Release from Fibers in the CeA
(A) The PVN, SON, and AN (coronal section) display mCherry expression after infection with OT promoter-ChR2-mCherry rAAV.
(B) Scheme of experimental set up showing (in coronal plane) the three hypothalamic nuclei and (in horizontal plane) the electrophysiological slice preparation
(see Experimental Procedures). Labels c, d, and e refer to pipettes used for recordings in (C), (D1) and (D2), and (E1) and (E2), respectively, with pie charts
indicating proportions of cells responding to BL.
(C) Action potentials evoked by 10 ms, 10 Hz, and currents induced by 1 s continuous BL stimulations in a fluorescent PVN cell.
(D1 and D2) Effects of 20 s BL (30 Hz, 10ms pulses) on CeL AP frequencies, both in CeL.
(D1) Example traces of APs recorded (1) without BL, (2) after BL, (3) with OTA alone, (4) with OTA + BL, and (5) BL after OTA washout.
(D2) Left: average AP frequencies of CeL neurons (1) without BL, (2) after BL, (3) with OTA alone, (4) OTA + BL, or (5) together with NBQX (n = 5) and after washout.
Right: in presence of PTX without BL (n = 5).
(E1 and E2) Effects of BL in CeL (except where indicated) on IPSCs recorded in CeM neurons.
(E1) Example traces of IPSCs recorded (6) without BL, (7) after BL, (8) OTA + BL, (9) BL after OTA washout, and (10) BL in presence of PTX. (Example trace, below
[B].) Rate-meter trace of IPSC frequencies recorded from a CeM neuron in response to (7) BL, (8) presence of OTA + BL, and (9) OTA washout + BL.
(E2) Average IPSC frequencies after BL in presence of OTA (first panel) (n = 9), NBQX only (second panel) (n = 5), both OTA and NBQX (third panel) (n = 4), PTX
(fourth panel) (n = 4), and BL focused either on CeM or CeL (fifth panel) (n = 6). Statistical significances: Student’s t test, ++ p < 0.01; one-way ANOVA, *p < 0.05.
Blue squares represent BL stimulation.
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Figure 5. Evoked Release of Endogenous Oxytocin Attenuates Freezing Behavior
(A) Left: scheme of the placement of guide cannulae and optic fibers for BL application in CeL. Right: detail of the tip of the glass fiber position obtained after
microinjection of fluorescent beads (see Experimental Procedures). Top right: example picture of fluorescent beads injected in CeL. Bottom right: example of
eight correctly targeted CeLs in the left hemisphere (four of BL group, in blue; four of OTA + BL group, in red) and the three outliers (dotted blue circles).
(B) Three-day experimental contextual fear-conditioning protocol. Vertical black bars show the timing of foot shock during conditioning. Grey segments, pre-
conditioning procedure including light anesthesia of the animal; blue segments, BL application.
(C1–C3) Effects of BL application during exposure to fear context.
Neuron
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Evoked Axonal Oxytocin Releasesuggests that the BL-evoked release of OT in the CeA is accom-
panied by the release of another factor, which requires AMPA-
receptor activation. Indeed, we found that NBQX alone also
decreased BL-induced IPSC responses in the CeM (Figure 4E2,
second panel).
Blue-Light-Induced Activation of ChR2-Expressing OT
Axons in the CeA Suppresses Contextual Freezing in
Fear-Conditioned Rats
To determine whether BL-evoked release in vivo of endogenous
OT in the CeA affects behavior, we expressed the ChR2-
mCherry fusion protein in all hypothalamic OT structures of virgin
female rats (see above). These rats were implanted bilaterally
with guide cannulae to target blue-laser-coupled optical fibers
above the CeA. Correct placement of the cannulae and fibers
was verified by injections of fluorescent beads and post hoc
analysis. Based on incorrect positioning, three rats (in which
BL, as a consequence, did not decrease freezing responses)
were excluded from further analysis. (Figure 5A, see also Exper-
imental Procedures). To ensure basic activation of the amygdala
during the behavioral experiments, we trained all rats in a 2-day
contextual fear-conditioning protocol (see Figure 5B and Exper-
imental Procedures) that resulted in similar freezing in the
majority of animals (n = 25) after 2 days of conditioning (Figures
5C1 and 5D1). One animal was excluded from the experiment
due to unusually low freezing levels. Hormonal cycle did not
appear to affect these freezing levels (Figure S5).
To assess acute effects of BL on freezing behavior, we placed
rats on day 3 in the fear-conditioning box after optic fibers had
been inserted through the guide cannulae to target the CeL. All
rats exhibited maximal freezing upon and throughout exposure
to the context (Figure 5C1). After 10 min, 10 ms, 30 Hz BL pulses
were given for either 20 or 120 s. As expected from the central
role of the CeM in freezing behavior (Ciocchi et al., 2010;
Haubensak et al., 2010) and the inhibitory effects of BL on the
CeM in vitro (Figure 4), BL efficiently decreased freezing (from
57.5 ± 0.9 to 32.1 ± 5.6 s/min, n = 6; one-way ANOVA, p <
0.05; Figure 5C1). The onset of this decrease (Figure 5C2; see
also Movie S1) started in two rats as fast as 2 s after BL onset
and on average with a delay time of 21.5 ± 9.7 s across all
animals (n = 6). Freezing returned after 70 ± 21 s upon termina-
tion of the 20 s BL stimulation and 108 ± 20 s after the 120 s
BL exposure (n = 3 per group). The inhibiting effects of BL ap-
peared specific to the fear-induced freezing response, because
BL exposure in the same animals in a non-fear-conditioning
context did not affect basic locomotor activity (Figure 5C3).
To confirm involvement of endogenous OT release in these BL
responses, we injected OTA on day 3 through the same guide(C1) Mean effects upon BL for 20 s (dark blue, n = 3) or 120 s (light blue, n = 3).
(C2) Top: example of BL effects on one animal. Each point represents the time o
animals (color coded by dots) after 20 s (dark blue bar) or 120 s (light blue bar), w
(C3) Effect of BL on mobility, measured for the same animals, at day 4 in a differ
(D1–D3) Effects of BL application prior to exposure to the context.
(D1) Pretest quantification of freezing behavior obtained at the end of conditionin
(D2) Time course of freezing behavior for control (Ctrl, n = 4), 120 s BL (BL, 30H
(OTA, n = 4).
(D3) Mobility of different groups of animals (OTA, BL, and OTA + BL) at day 3 in the
significance: one-way ANOVA,*p < 0.05 in (C1)–(C3); two-ways ANOVA, + p < 0.cannulae through which the optic fibers were subsequently in-
serted and applied BL immediately for 120 s before the rats
were re-exposed (after removal of the optic fibers) to the fear-
conditioning context. We thus measured the remaining block
on the effects of BL by OTA, while at the same time providing
more freedom of movement to the rats (now unobstructed by
any attached optic fibers). We compared freezing behavior
between four groups of rats, namely ‘‘Ctrl’’ (no BL, but optic
fibers inserted prior to testing), ‘‘OTA’’ (OTA injected + optic
fibers without BL), ‘‘BL’’ (BL application prior to exposure to
context) and ‘‘OTA + BL’’ (injection of OTA followed by BL appli-
cation prior to exposure to context). Ctrl or OTA-injected rats
exhibited high freezing levels (Figure 5D2) comparable to those
measured previously (Figure 5C1). On the other hand, BL-
exposed rats immediately exhibited lower freezing levels upon
exposure to the context. This reduced freezing persisted in these
more freely moving rats over the first half of the testing period
(Figure 5D2).
Of interest and importance, the BL inhibition of freezing was
completely abolished in rats injected with OTA, which now ex-
hibited similar freezing levels as rats that had not been exposed
to BL (Figure 5D2). Because all rats demonstrated similar levels
of freezing responses after 2 days of fear conditioning (Fig-
ure 5D1), and their mobility (tested by placing the animal in
a different context) was not affected by BL exposure (Fig-
ure 5D3), these effects seem specific to the pharmacological
and optogenetic exposures of the CeL. In conclusion, our in vivo
findings, in addition to our in vitro findings, reveal that the activa-
tion of local OT fibers of hypothalamic origin triggers specific,
OT-R-mediated reduction of fear responses, thereby further
demonstrating the functional and physiological role of these
OT projections.
Synaptic Contacts by Hypothalamic OT Projections as
Revealed by Retrograde Tracing with Deletion-Mutant
Pseudotyped Rabies Virus
The above findings suggest a specific targeting of OT from the
hypothalamus to the CeA through local release from axonal
endings. To retrogradely trace their precise cellular origins, we
employed the deletion-mutant pseudotyped rabies virus
SADDG-EGFP (EnvA) (henceforth termed PS-Rab-EGFP, see
Figure S6A for expression efficiency). We delivered into several
hypothalamic projection sites, including the CeA, of 10-day
pregnant rats (Figure 6A) two rAAVs expressing from the chicken
b-actin-enhanced CMV promoter the avian sarcoma and leuco-
sis virus receptor (TVA, coupled by IRES to tdTomato) and the
rabies glycoprotein (RG). Expression of TVA is essential for PS-
Rab entry into neurons, whereas expression of RG allowsf freezing during 10 s. Bottom: offset and return of total freezing for individual
ith averages of dot values represented by gray bars.
ent contextual box.
g day 2.
z, 10ms pulses, n = 4), after OTA + BL (OTA + BL, n = 4), and after OTA alone
context without exposure to US during day 1 and 2 (n = 3 per group). Statistical
05 BL versus Ctrl; p < 0.05 BL versus OTA + BL in (D1)–(D3).
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Figure 6. PS-Rab-Based Retrograde Labeling of Hypothalamic OT Neurons Monosynaptically Projecting to the CeA
(A) Pregnant rats were injected into the CeA with rAAVs expressing TVA-IRES-tdTomato and RG, followed by PS-Rab-EGFP.
(B) Primary infected neurons in the CeA show colocalization of tdTomato and EGFP (insets).
(C) Retrogradely labeled OT-positive neurons found in the SON, PVN, and especially in AN.
(D) EGFP-positive axonal endings in the posterior pituitary are also positive for OT (insets), indicating that magnocellular OT neurons project axons to the posterior
pituitary and CeA.
(E) Schematic drawing of results in (C) and (D). Green cell denotes OT neurons, which project green collaterals simultaneously to the central sites (CeA, red cell)
and to the posterior pituitary, from where OT reaches general circulation. Scale bars represent 100 mm in (B) and (D), 20 mm in the inset of (B), 50 mm in (C), and
20 mm in the insets of (D). BLA, basolateral amygdala; BSTIA, bed nucleus of stria terminalis (intraamygdaloid division); CPu, caudate putamen; ic, internal
capsule; LA and MeA, lateral and medial amygdala; pp, posterior pituitary.
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Evoked Axonal Oxytocin Releasemonosynaptically restricted retrograde transsynaptic transmis-
sion of PS-Rab (Wickersham et al., 2007). Subsequent injection
of PS-Rab-EGFP into the same sites (CeA; Figure 6A) permitted
analysis of retrogradely connected neurons on day 7 of lactation.
Whereas primarily infected neurons in the injected sites should
emit both red (tdTomato) and green (EGFP) fluorescence, retro-
gradely labeled neurons should emit green fluorescence only
(Figure 6B). After infection of the CeA, we found EGFP-positive
neurons mostly in the areas surrounding the PVN and SON,
with a small number of neurons containing both OT and EGFP
immunoreactivity (Figure 6C). As expected from the antero-
grade-labeling study (see Figure 3A), the highest number of560 Neuron 73, 553–566, February 9, 2012 ª2012 Elsevier Inc.double-positive neuronswas observedwithin the AN (Figure 6C),
identifying the AN as the major source for the OT innervation of
the CeA. Neurons expressing only green fluorescence were
also observed in various extrahypothalamic sources of CeA
innervation (Figure S6B; Swanson and Petrovich, 1998), and
injections of both rAAVs in two other hypothalamic targets
(the nucleus accumbens, Acb, and nucleus of solitary tract,
NTS) also resulted in EGFP-positive neurons in the hypothal-
amus (Figure S6C), attesting to the efficient retrograde mono-
transsynaptic labeling with this method. Thus, these findings
confirm the presence of functional monosynaptic hypothalamic
projections in the CeA.
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Fear Responses
Hypothalamic nuclei contain magno- and parvocellular OT
neurons, which are nonsegregated within the PVN (Swanson
and Sawchenko, 1983), and both were indeed labeled by our
OT-specific rAAVs (see Figure 1B; Figure S1A). Becausemagno-
cellular neurons, in contrast to parvocellular neurons, also send
collateral branches to the posterior pituitary in addition to the
extrahypothalamic forebrain, retrograde labeling of magnocellu-
lar brain projections may anterogradely label posterior pituitary
endings. We used pseudotyped rabies virus to identify the
magno- versus parvocellular origin of forebrain projections.
Infection of CeA and Acb by PS-Rab-EGFP resulted in a fluores-
cent label in the pituitary in both cases (Figures 6D and S6C, top),
but not following infection of the NTS (Figure S6C, bottom panel).
Injection of the unpseudotyped rabies virus (UPS-Rab) in the
pituitary (which can infect intact or damaged axons without the
presence of TVA receptor) did not lead to labeling in the hypo-
thalamus (Figure S6D), thereby confirming the specific transsy-
naptic labeling by PS-Rab. In summary, although these findings
do not exclude a contribution by the parvocellular OT neuron
population to innervation of all three nuclei, they provide clear
evidence for the magnocellular origin and axon collateral nature
of OT fibers in the CeA and Acb.
DISCUSSION
A longstanding unresolved question in the field of OT signaling in
the brain concerns the precise sites of OT release and the path-
ways andmechanism through which OT reaches its target struc-
tures. The prevailing hypothesis in the field has been in favor of
a dendritic release of OT in the hypothalamus, followed by OT
diffusion to target areas. Through a combination of anatomical,
electrophysiological, optical, and behavioral approaches, we
provide in the present study morphological and functional
evidence for the presence of axonal endings through which
OT, produced in the hypothalamus, can reach the CeA and be
locally delivered to exert direct effects both at the cellular and
behavioral level.
Magnocellular OT Neurons Project Axonal Collaterals
to Diverse Brain Regions
Application of cell-type-specific rAAV results in infection of the
vast majority of OT neurons in both virgin and lactating rats.
However, taking advantage of the higher transcriptional activity
of virally introduced OT promoter in lactating rats and, hence,
higher levels of expression of Venus (at least 3-fold; Figures 1C
and S1) we visualized and semiquantified OT projections in 34
forebrain regions. The distribution of Venus-positive fibers in
the forebrain agreed with anatomical studies from the 1980s
(Sofroniew, 1983; Buijs, 1983), which showed OT-immunoreac-
tive fibers in a limited number of forebrain structures, such as
the tenia tecta, Acb, lateral septum, amygdala, and hippo-
campus. However, due to our highly sensitivemethod for detect-
ing soluble marker proteins (Grinevich et al., 2005) and higher
levels of Venus expression in lactating rats, we found many
more fine Venus-positive axons in all major forebrain regions
than by direct staining for OT. Moreover, classical immunohisto-chemistry does not reveal the sources of these fibers, whichmay
originate from the PVN, SON, or AN. According to our results, the
PVN and AN neurons project extensively to forebrain structures,
whereas the SON contributes less to forebrain innervation. But
even from the SON, which features only magnocellular neurons,
a moderate number of fibers were observed in five forebrain
regions (the horizontal limb of the diagonal band of Broca,
Acb, CeA, lateral septum, and CA1 of the ventral hippocampus).
Additional evidence that magnocellular neurons project to
higher brain regions was obtained with PS-Rab delivered into
the CeA or the Acb. After injection of EGFP-expressing PS-
Rab into these structures, we observed EGFP-positive back-
labeled OT neurons residing in magnocellular nuclei, as well as
their axonal terminals in the posterior pituitary. Importantly,
only magnocellular hypothalamic neurons, but no other neuronal
cell types, project to the posterior pituitary lobe (Brownstein
et al., 1980; Sofroniew, 1983; Swanson and Sawchenko, 1983;
Burbach et al., 2001).
In support of our observations, injection of the retrograde
marker fluorogold into the Acb of voles led to the appearance
of back-labeled OT neurons in the PVN and SON, with fluoro-
gold-containing terminals in the posterior pituitary (Ross et al.,
2009). In contrast, injection of PS-Rab into the NTS (Figure S6B)
resulted in back-labeling of PVN parvocellular OT neurons,
which do not project to the posterior pituitary (Sawchenko and
Swanson, 1983; Swanson and Sawchenko, 1983). Collectively,
the PS-Rab data in conjunction with light and, in particular, elec-
tron microscopic results provide compelling evidence that the
fibers in the CeA and Acb are axonal collaterals of magnocellular
OT neurons.
Our finding that magnocellular OT neurons simultaneously
project to forebrain structures and the posterior pituitary is
consistent with results demonstrating that the induced central
and peripheral OT releases can be associated, for instance, in
a situation of stress (Neumann, 2007). More specifically, it was
previously demonstrated that an ethologically relevant stressor
(such as forced swim in rats) induces an increase in OT plasma
levels (Wotjak et al., 1998), as well as OT release within the CeA.
Inhibitory Effects of Endogenous OT Release in the
Central Amygdala
Our anatomical results provide the basis for OT action within the
CeA in both virgin and lactating rats. Although the density of OT
fibers is lower in virgin than in lactating animals, the profile of
axonal innervation of the CeA was similar in animals of both
groups. In the CeM, we detected smooth nonbranching fibers
which exceed the axons in the CeL in length. This type of fiber
appears to represent transitory axons, traversing the CeM with
no synaptic contacts. The appearance of axons in the CeL was
strictly different: they exhibited single small branches, often pos-
sessing varicosities (as a substrate for presynaptic terminals; see
Figures 3F, S3A, and 6), which may also represent sites for
axonal OT release.
In accordance with this proposition, we found that release of
endogenous OT from axonal endings, triggered by blue-light
exposure of the CeL (but not the CeM), significantly modified
the CeA signaling by increased activity of GABAergic inter-
neurons in the CeL through an OT-R-dependent process. TheNeuron 73, 553–566, February 9, 2012 ª2012 Elsevier Inc. 561
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aptic currents in CeM neurons, which were completely abolished
by GABA(A) receptor antagonists, thus identifying their inhibitory
nature. Accordingly, this increase of endogenous OT, by inhibit-
ing neurons in the CeM, the main output center of the CeA,
caused an attenuation of the freezing response (see below). It
therefore appears that even relatively sparse innervation by
OT-releasing axons in the CeL is sufficient to trigger significant
inhibition through activation of GABAergic neurons projecting
from the CeL to the CeM.
Our light and electron microscopic results demonstrate that
OT neurons form synapses in the CeL analogous to OT-contain-
ing synapses within the SON (Theodosis, 1985), NTS (Peters
et al., 2008), and at the lateral border of the hypothalamic ventro-
medial nucleus (Griffin et al., 2010). Furthermore, the asymmetric
nature of these synapses and the occurrence of VGluT2 in theOT
axons raise the question whether glutamate may be coreleased
with OT. Both our recordings in the CeL and CeM indeed re-
vealed, in the presence of the OT-R antagonist OTA, a remaining
blue-light-evoked response that could be efficiently blocked by
AMPA-receptor blockade, consistent with presynaptic gluta-
mate release. Only application of NBQX revealed that AMPA-
receptor activation is not required for OT release, which would
preclude an involvement of presynaptic AMPA receptors on
OT fibers. However, other ionotropic and possibly metabotropic
glutamate receptors may facilitate OT release by contributing to
axonal depolarization upon presynaptic glutamate release. In
view of the recent discovery of distinct, mutually inhibitory
neuronal populations in the CeL (Ciocchi et al., 2010; Haubensak
et al., 2010), it will be of interest to determine how individual
neuronal activity in this nucleus may be differentially affected
by endogenous OT and/or glutamate release.
Behavioral Effects of Endogenous OT Release
in Amygdala
A considerable and long-standing body of evidence indicates
that OT can exert important effects on anxiety and fear
responses by its effects in the CeA, following initial studies by
Roozendaal and coauthors (Roozendaal et al., 1992a, 1992b,
1993). Further, in vivo experiments indicated that enhanced
hypothalamic OT expression (Caldwell et al., 1987) and dendritic
release (Neumann, 2007) might underlie the alterations in behav-
ioral patterns seen during lactation, such as anxiety and aggres-
sion (Ferris et al., 1992; Lubin et al., 2003). Notably, in a rat strain
with high anxiety-related behavior, the CeA level of OT was
prominently increased in parallel with more intense maternal
care, maternal offensive, and stress-coping behaviors, and
these effects were reversed by local OTA infusion (Bosch
et al., 2005). Very recent work also reports an effect on fear
behavior by exogenous OT infusion into the CeA (Viviani et al.,
2011). In this context, our study demonstrates that the blue-
light-stimulated release of endogenous OT in the CeA drastically
suppresses freezing behavior of fear-conditioned rats, with the
effect abolished by infusion of OTA. The rapid onset and the
time course of the reversibility of these effects provide further
evidence in favor of a local release of OT from these fibers in
the central amygdala, as opposed to slow diffusion from distant
hypothalamic nuclei.562 Neuron 73, 553–566, February 9, 2012 ª2012 Elsevier Inc.Our retrograde transsynaptic tracing with PS-Rab further
assigned a magnocellular origin for OT in the hypothal-
amus. Indeed, Krause et al. (2011) reported recently how an
osmotic challenge (dehydration) specifically activated
OT-producing magnocellular neurons in the PVN, which in
turn evoked profound anxiolytic effects. Taken together, these
findings place the magnocellular neurons at a crucial
intersection of transmitting environmental stimuli to the amyg-
dala and provide a pathway through which these stimuli can
lead to rapid OT-mediated regulation of anxiety and fear
responses.
In conclusion, we employed an efficient and specific OT
promoter, which allowed us to genetically manipulate OT
neurons via insertion or deletion of genes of interest. Although
we demonstrated the cell-type-specific targeting of OT neurons
in rats and mice (unpublished data), the same OT promoter
should work in other species because it is highly conserved
among mammals. Furthermore, our evidence for functional
OT axons in the CeA provides proof of principle for the local,
targeted release of a modulatory neuropeptide by long-range
axon collaterals in other forebrain regions, which can be used
to specifically control region-associated behaviors. Our physio-
logical and anatomical findings now open the technical pros-
pect for studying the effects of endogenous OT release in
various brain regions with respect to distinct forms of social
behavior (Landgraf and Neumann, 2004; Ludwig and Leng,
2006; Donaldson and Young, 2008; Lee et al., 2009; Ross
and Young, 2009). Because the role of OT in human psychopa-
thology has become subject of many translational studies (De
Dreu et al., 2010; Simeon et al., 2011; Skrundz et al., 2011),
the experimental alteration in endogenous OT release may
open the way to dissect OT-related pathogenic mechanisms
underlying emotional and psychiatric disorders in human
patients.
EXPERIMENTAL PROCEDURES
Cloning of rAAV Vectors
For generating rAAVs with specific expression in OT cells, we used the soft-
ware BLAT from University of California, Santa Cruz (http://genome.ucsc.
edu/cgi-bin/hgBlat) and selected a conserved 2.6 kb promoter directly
upstream of the OT gene exon 1. This DNA was amplified from an EcoRI-
linearized BAC clone RP24-388N9 (RPCI-24 Mouse, BACPAC Resources)
using a 50 primer containing a NotI-restriction site (50-ATTAGCGGCCGCA
GATGAGCTGGTGAGCATGTGAAGACATGC-30) and a 30 primer with a SalI-
restriction site (50-ATTAGTCGACGGCGATGGTGCTCAGTCTGAGATCCGCT
GT-30), subcloned into pBlueScript SK and further cloned into the rAAV2 back-
bone, pAAV-aCaMKII-htTA, thereby substituting the aCaMKII-promoter. The
resulting rAAV expression vector was used for exchange of the htTA-gene
for the following genes of interest: Venus, Channelrhodopsin-2 -mCherry,
Tau-EGFP, and Synaptophysin-EGFP.
We also designed rAAV vectors equipped with the cytomegalovirus
enhancer/chicken-b-actin promoter, expressing the rabies glycoprotein (RG)
and the avian sarcoma and leucosis virus (TVA) receptor linked via an internal
ribosomal entry site (IRES) to the fluorescent marker tdTomato.
Production of rAAVs
Production and purification of rAAVs (Serotype 1/2) were as described
(Pilpel et al., 2009). rAAV genomic titers were determined with QuickTiter
AAV Quantitation Kit (Cell Biolabs) and RT-PCR using the ABI 7700 cycler
(Applied Biosystems). rAAVs titers were 1010 genomic copies per ml.
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Propagation of PS-Rab was performed as reported previously (Wickersham
et al., 2010; Rancz et al., 2011). Briefly, after infection of BHK-B19G cells by
SADDG-GFP or SADDG-mCherry, the supernatant containing unpseudotyped
deletion-mutant rabies virus (UPS-Rab) was filtered and stored at 80C
(Figures S6A and S6D). Rabies virus pseudotyping (Wickersham et al., 2010;
Rancz et al., 2011) and purification were as with lentivirus (Dittgen et al., 2004).
Animals
For anatomical studies, adult female Wistar rats were separated into 11
groups, according to the purposes of the study (Table S1). For stereotactic
coordinates (Paxinos andWatson, 1998) and volumes of virus-containing solu-
tion, see Table S2. Stereotactic injections were performed as described (Cetin
et al., 2006).
Histology
Double Fluorescence Immunohistochemistry
Vibratome sections of brains (50 mm) perfused with 4% paraformaldehyde
(PFA) were stained with chicken anti-GFP (Abcam; 1:10,000) and combined
with various antibodies against the following: OT and VP (1:300; provided by
Harold Gainer; Ben-Barak et al., 1985); NeuN (Chemicon; 1:1,000); VGluT2
(Synaptic Systems; 1:1,000); and tdTomato (1:1,000; Clonthech). Whereas
Venus and EGFP signals were enhanced by FITC-conjugated IgGs, other
proteins and markers were visualized by CY3-conjugated or CY5-conjugated
antibodies (1:300; Jackson Immuno-Research Laboratories). All images were
acquired on a confocal Leica TCS NT and Zeiss LSM5 microscopes; digitized
images were analyzed using Adobe Photoshop (Adobe).
Cell-Type Specificity and Inducibility of Venus Expression in OT
Neurons
To analyze the specificity of OT promoter-Venus rAAV in neurons of the PVN
and SON, we counted all Venus- and OT-immunoreactive neurons (80–150
neurons/section dependent on the anterior-posterior Bregma level) in three
sections per animal at three different rostro-caudal Bregma levels
(PVN: 1.5, 1.8, and 2.0 mm; SON: 1.1, 1.4, and 1.7 mm). Sections
were taken from three virgin rats and three lactating rats, the latter killed on
day 14 after parturition. For the analysis of the AN of three virgin and three
lactating rats, we counted all Venus- and OT-immunoreactive neurons in
two sections per animal (due to the shorter anterior-posterior extent of the
AN compared to the SON and PVN) at two different Bregma levels
(rSON: 2.0 and 2.1 mm; CN: 1.4 and 1.5 mm; DLN: 2.1 and
2.2 mm) and on average per section 12 neurons for the CN, 35 neurons for
the DLN, and 19 neurons for the rSON. The number of identified and counted
cells in both groups of animals was 4,774 neurons in total (more details on cell
numbers are in Table 1). The comparison between the numbers of identified
neurons per each rat and structure between groups of virgin and lactating
rats was evaluated statistically (see below). The duration of infection was
similar in all animals (25 days; see Table S1).
To exclude the possibility that our viral vector also infects VP neurons, the
same analysis was performed on SON sections of three rats (see above).
The sections were costained with antibodies against OT (visualized by CY3-
conjugated secondary antibodies) and VP (visualized with CY5-conjugated
antibodies) for subsequent counting of all cells visible in the SON positive for
Venus, OT, and VP at three different Bregma levels (1.1,1.4, and1.7mm).
To analyze the inducibility of our viral vector, we analyzed the SONs of preg-
nant rats and virgin rats 1 day before delivery, on the day of delivery, and the
day after delivery with Fiji (National Institute of Mental Health) to manually
measure direct fluorescence intensity and cell sizes (25 cells/section; 3–4
sections per rat, 3 rats in each group, 12 animals in total). The selection of cells
in the SON was done randomly at similar Bregma levels of the rostro-caudal
extend of the nucleus (Bregmas: 0.92, 1.3, 1.4, and 1.6 mm). The total
number of cells counted in each group was 180 (virgins), 180 (day before
delivery), 240 (day of delivery), and 180 (day after delivery).
Statistical significance was determined by Student’s t test for colocalization
experiments and by one-way ANOVA for the inducibility of virally introduced
OT-promoter fragment during peripartum period. Statistical analysis was
performed with use of Prism 5 for Mac OS X. Results are presented as
mean ± SEM. p < 0.05 were considered statistically significant.Electron Microscopy
Rats were perfused transcardially with 4% PFA in phosphate buffer containing
0.05% glutaraldehyde at pH 7. The 50 mm coronal brain sections containing
the CeA were incubated with rabbit polyclonal anti-GFP antibodies (Molecular
Probes; 1:5,000). The GFP signals were visualized using the standard avidin-
biotin complex protocol and DAB chromogen, intensified by silver-gold (Lipo-
sits et al., 1986) and processed (Eliava et al., 2003).
Electrophysiological In Vitro Experiments
Slice Preparation. Four-to-eight weeks after injection of ChR2-mCherry rAAV
into the SON, PVN, and AN of adult virgin female rats, brains were removed,
cut into 400 mm horizontal slices (described in Huber et al., 2005), and kept
in artificial cerebrospinal fluid in the dark to avoid ChR2 activation.
Electrophysiological Recordings. Whole-cell patch-clamp recordings were
visually guided by infrared videomicroscopy (DM-LFS; Leica), using 4–9
MOhm borosilicate pipettes filled with 140 mM KCl, 10 mM HEPES, 2 mM
MgCl2, 0.1 mM CaCl2, 0.1 mM BAPTA, 2 mM ATP Na salt, 0.3 mM GTP Na
salt (pH 7.3), 300 mOsm, and amplified with an Axopatch 200B (Axon Instru-
ments). For cell-attached recordings, KCl was replaced with KMeSO4.
ChR2-mCherry expression was identified by fluorescent microscopy and
post hoc immunohistochemistry.
Blue-Light Stimulation. For in vitro experiments, optical stimulation was
done via a mercury lamp (Short Arc 103W/2, Osram; 5 mW/mm2) in combi-
nation with a shutter (VS25S22M1R1, Uniblitz) or a TTL-pulsed LED source
(LXHL-LB3C, Roithner; 10 mW/mm2), both yielding similar results.
Behavioral Experiments
Fear Conditioning
Following recovery from guide cannulae implantation (1 week), female virgin
rats of random hormonal cycle were exposed to a contextual fear-conditioning
protocol. This consisted of three sessions on consecutive days (Figure 5B). On
day 1, rats were individually introduced in the conditioning box (45 3 18 3
25 cm) and after 10 min received a first series of seven electric shocks (0.8
mA) at random intervals (15–120 s) over 7 min. After the last shock, the rats
were left in the box for 3 more min. BL was applied in 10-ms pulses at 30 Hz
via a glass fiber protruding 2 mm beyond the lower end of the cannulae and
delivered light intensity of 10 mW. OTA injection was done via two injectors
(cut to fit the 5.8 mm guide cannulae protruding 2 mm beyond the lower end of
the cannulae) that were bilaterally lowered into the guide cannulae, connected
via polyten tubing to two Hamilton syringes that were placed in an infusion
pump, and 0.5 ml of liquid containing 21 ng OTA was injected in each hemi-
sphere at 0.25 ml/min over a 2 min period.
Application of BLduring Fear-Context Exposure. Onday 2, the ratswere habit-
uated to theglassfibersby inserting them into thecannulae for thecompletedura-
tionof theprotocol,whichwassimilar to theoneofday1 (Figure5C).Onday3, the
rats were tested in the context for 10min before receiving bilateral BL stimulation
for either 20 s or 120 s. The effect was video recorded for the complete 20min of
the test (see Figure 5B). Freezing time was analyzed per 10 s intervals.
Application of BL prior to Fear-Context Exposure. On day 2, rats received in
addition a sham blue-light application during 6 min of very light isoflurane (5%
induction, 1% for maintenance), during which time the glass fiber was inserted
into the guide cannulae, as on day 3, without exposure to BL (Figure 5D). At the
end of day 2, freezing levels were assessed to exclude differences possibly
caused by the implantation of the cannulae before the rats were divided in
four groups for testing on day 3 (see Figure 5D). On day 3, the rats received
(1) sham BL (insertion of the glass fiber without exposure to BL), (2) BL, (3)
OTA alone, or (4) OTA and BL. BL was applied bilaterally for 2 min, first on
the right and then on the left hemisphere. Rats were allowed 2 min of recovery
from anesthesia and introduced in the context, where their behavior was video
recorded during a 20 min period without electric shocks. Freezing was as-
sessed per periods of 1 min intervals.
Effects of BL on Mobility. Animal mobility was assessed using photobeam
sensors placed at 1 cm distances. Each time of beam interruption by the rat
was counted by the software as one passage (MED-PC, Med Associates).
Blue-Light Stimulation In Vivo and Verification of Optic Fiber
Positions
For the in vivo experiments, we used two blue lasers (l 473nm, output of
150mW/mm2,DreamLasers) coupledwith optical fibers (BFL37-200-CUSTOM,Neuron 73, 553–566, February 9, 2012 ª2012 Elsevier Inc. 563
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inserted above the region of interest via guide cannulae (C313G-SPC 22Gauge,
5.8 mm below pedestal, PlasticOne). Guide cannulae were chronically im-
planted under isoflurane anesthesia (5% induction, 2% maintenance) at
stereotaxic positions of 2.5 mm anteroposterior and 3.9 mm lateral from
Bregmaandwere stabilizedwithdental cement.On thedaysof the experiments,
the optic fiberswere inserted through the cannulae and fixed through a screw at
a position 2 mm protruding beyond the lower end of the cannula. This should
lead to a specific stimulation of the CeL, as prevalent measurements with BL
stimulations in rodent brain have shown that the BL of the laser does not pene-
trate the tissue further than 500 mm (Yizhar et al., 2011).
After the behavioral experiments, 0.5 ml of green fluorescent latex micro-
spheres (Lumafluor) was injected 2 mm below the lower end of the cannulae
(i.e., the same position as the optical fibers). Rats were subsequently killed
to assess the placement of the tip of the injector by sectioning the brain with
a vibratome into 400 mm slices (see Figure 5A).
Drugs and Concentrations
Oxytocin-receptor antagonist d(CH2)5-Tyr(Me)-[Orn8]-vasotocin (1 mM, OTA,
Bachem), glutamate-receptor (AMPA) antagonist 1,2,3,4-tetrahydro-6-nitro-
2,3-dioxo-benzo[f]quinoxaline-7-sulfonamide (0.4 mM, NBQX, Sigma), ()
bicuculline methiodide (Sigma), or picrotoxin (50 mM, PTX, Sigma) were bath
perfused for the in vitro experiments for 20 min before and several min beyond
the expected response to BL application.
Data Acquisition and Analysis
Patch-clamp signals were acquired with pClamp 9.0 (Axon Instruments),
filtered at 5 kHz, and digitized at 10 kHz with a Digidata 1200 A/D (Axon Instru-
ments). Currents were detected and analyzed using Minianalysis Program 6.0
(Synaptosoft).
Statistical Analysis
Data in text are expressed as mean ± SEM.
For in vitro experiments, one-way ANOVAwith factor treatment (i.e., respec-
tive drug used) was used for assessment of pharmacological effects;
Student’s t test was used for assessment of BL effect without drug.
For in vivo experiments, one-way ANOVA with factor time was used for
assessment of the BL effect on both freezing and mobility; Student’s t test
was used for comparison of duration of BL effect. For the experiments in Fig-
ure 5D, two-way repeated ANOVA with factors treatment (Ctrl versus BL; Ctrl
versus OTA + BL; BL versus OTA) and time were used for assessment of BL
effect in presence of pharmacological effects on freezing response.
When the ANOVA test was significant, the Tukey test was used for post hoc
multiple comparisons. Differences were considered significant for p < 0.05
(*, + and ; ANOVA) or p < 0.01 (++, t test). All statistical tests were performed
with StatView 5 (StatView, SAS Institute).
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